Jacob Asset Management of New York »

Neubase Therapeutics shares owned by Jacob Asset Management of New York

Quarter-by-quarter ownership of Neubase Therapeutics (NBSE) shares owned by Jacob Asset Management of New York from 13F filings

Historical chart of Jacob Asset Management of New York investment in Neubase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neubase Therapeutics held by Jacob Asset Management of New York consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neubase Therapeutics by Jacob Asset Management of New York

Quarter filed Position value Share count Share price at filing
2023-09-30 $14k 16k 0.87
2023-06-30 $29k 16k 1.85

More positions owned by Jacob Asset Management of New York

Draftkings Com Cl A (DKNG)
Inspired Entmt (INSE)
Identiv Com New (INVE)
Cloudflare Cl A Com (NET)
Optimizerx Ord (OPRX)
Cantaloupe (CTLP)
Lantronix Com New (LTRX)
Doximity Cl A (DOCS)
Twilio Cl A (TWLO)
Mongodb Cl A (MDB)
Immersion Corporation (IMMR)
Block Cl A (SQ)
Hashicorp Com Cl A (HCP)
Digital Turbine Com New (APPS)
Porch Group (PRCH)

View all positions for Jacob Asset Management of New York

Top funds holding Neubase Therapeutics

DME Capital Management
Greenlight Capital
Point72 Asset Management
Carnegie Mellon University
Vanguard Group
Kestra Advisory Services
Springbok Capital Management
Geode Capital Management
UBS Group
Tower Research Capital
Cubist Systematic Strategies
Bank of America Corporation
First Manhattan
Royal Bank of Canada
Wells Fargo & Company

View all funds holding Neubase Therapeutics